derivatives with prostanoid FP-receptor agonistic activity as potent ocular-hypotensive agents. Biol Pharm Bull 26:1691-1695, 2003
2)Takagi Y, Nakajima T, Shimazaki A et al:Pharmacological characteristics of AFP-168(tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug. Exp Eye Res 78:767-776, 2004
3)桑山泰明・米虫節夫:0.015%DE-085(タフルプロスト)の原発開放隅角緑内障または高眼圧症を対象とした0.005%ラタノプロストとの第Ⅲ相検証的試験.あたらしい眼科 25:1595-1602,2008
4)桑山泰明・米虫節夫・タフルプロスト共同試験グループ:正常眼圧緑内障を対象とした0.015% DE-085(タフルプロスト)の眼圧下降効果に関するプラセボを対照とした多施設共同無作為化二重盲検第Ⅲ相臨床試験.日眼会誌 114:436-443,2010
5)Aihara M:Clinical appraisal of tafluprost in the reduction of elevated intraocular pressure(IOP)in open-angle glaucoma and ocular hypertension. Clin Ophthalmol 4:163-170, 2010
6)Izumi N, Nagaoka T, Sato E et al:Short-term effects of topical tafluprost on retinal blood flow in cats. J Ocul Pharmacol Ther 24:521-526, 2008
7)Mayama C, Ishii K, Saeki T et al:Effects of topical phenylephrine and tafluprost on optic nerve head circulation in monkeys with unilateral experimental glaucoma. Invest Ophthalmol Vis Sci 51:4117-4124, 2010
8)Akaishi T, Kurashima H, Odani-Kawabata N et al:Effects of repeated administrations of tafluprost, latanoprost, and travoprost on optic nerve head blood flow in conscious normal rabbits. J Ocul Pharmacol Ther 26:181-186, 2010
9)Kurashima H, Watanabe H, Sato N et al:Effects of prostaglandin F2a analogues on endothelin-1-induced impairment of rabbit ocular blood flow:comparison among tafluprost, travoprost, and latanoprost. Exp Eye Res 91:853-859,2010
10)Sugiyama T, Araie M, Riva CE et al:Use of laser speckle flowgraphy in ocular blood flow research. Acta Ophthalmol 88:723-729, 2010
11)Anderson DR, Patella VM:Automated Static Perimetry. 2nd ed. 121-190, Mosby, St Louis, 1999
を用いた視神経乳頭辺縁部組織血流の領域別評価.あたらしい眼科 27:1279-1285,2010
13)Dong Y, Watanabe H, Su G et al:Relaxing effect and mechanism of tafluprost on isolated rabbit ciliary arteries. Exp Eye Res 87:251-256, 2008
14)Fukano Y, Kawazu K:Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rat. Drug Metab Dispos 37:1622-1634, 2009
15)Sugiyama T, Kojima S, Ishida O et al:Changes in optic nerve head blood flow induced by the combined therapy of latanoprost and beta blockers. Acta Ophthalmol 87:797-800, 2009